annual EBIT:
-$175.62M-$136.63M(-350.44%)Summary
- As of today (July 1, 2025), SLNO annual earnings before interest & taxes is -$175.62 million, with the most recent change of -$136.63 million (-350.44%) on December 31, 2024.
- During the last 3 years, SLNO annual EBIT has fallen by -$143.36 million (-444.40%).
- SLNO annual EBIT is now -20634.24% below its all-time high of -$847.00 thousand, reached on December 31, 2013.
Performance
SLNO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$42.41M+$7.57M(+15.14%)Summary
- As of today (July 1, 2025), SLNO quarterly earnings before interest & taxes is -$42.41 million, with the most recent change of +$7.57 million (+15.14%) on March 31, 2025.
- Over the past year, SLNO quarterly EBIT has dropped by -$19.34 million (-83.81%).
- SLNO quarterly EBIT is now -2265.31% below its all-time high of $1.96 million, reached on March 31, 2013.
Performance
SLNO quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$194.96M-$19.34M(-11.01%)Summary
- As of today (July 1, 2025), SLNO TTM earnings before interest & taxes is -$194.96 million, with the most recent change of -$19.34 million (-11.01%) on March 31, 2025.
- Over the past year, SLNO TTM EBIT has dropped by -$141.06 million (-261.75%).
- SLNO TTM EBIT is now -10053.39% below its all-time high of $1.96 million, reached on March 31, 2013.
Performance
SLNO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SLNO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -350.4% | -83.8% | -261.8% |
| 3 y3 years | -444.4% | -539.6% | -578.2% |
| 5 y5 years | -657.1% | -387.6% | -549.1% |
SLNO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -629.7% | at low | -720.4% | +46.5% | -710.1% | at low |
| 5 y | 5-year | -657.1% | at low | -720.4% | +46.5% | -710.1% | at low |
| alltime | all time | <-9999.0% | at low | -2265.3% | +46.5% | <-9999.0% | at low |
SLNO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$42.41M(-15.1%) | -$194.96M(+11.0%) |
| Dec 2024 | -$175.62M(+350.4%) | -$49.98M(-37.0%) | -$175.62M(+26.5%) |
| Sep 2024 | - | -$79.33M(+241.5%) | -$138.79M(+101.7%) |
| Jun 2024 | - | -$23.23M(+0.7%) | -$68.81M(+27.7%) |
| Mar 2024 | - | -$23.07M(+75.5%) | -$53.89M(+38.2%) |
| Dec 2023 | -$38.99M(+62.0%) | -$13.15M(+40.4%) | -$38.99M(+25.7%) |
| Sep 2023 | - | -$9.36M(+12.6%) | -$31.01M(+11.7%) |
| Jun 2023 | - | -$8.31M(+1.7%) | -$27.75M(+8.4%) |
| Mar 2023 | - | -$8.17M(+58.0%) | -$25.61M(+6.4%) |
| Dec 2022 | -$24.07M(-25.4%) | -$5.17M(-15.3%) | -$24.07M(-4.6%) |
| Sep 2022 | - | -$6.10M(-1.0%) | -$25.23M(-6.1%) |
| Jun 2022 | - | -$6.16M(-7.1%) | -$26.86M(-6.6%) |
| Mar 2022 | - | -$6.63M(+4.8%) | -$28.75M(-10.9%) |
| Dec 2021 | -$32.26M(+1.0%) | -$6.33M(-18.2%) | -$32.26M(-4.4%) |
| Sep 2021 | - | -$7.74M(-3.9%) | -$33.75M(+2.0%) |
| Jun 2021 | - | -$8.05M(-20.6%) | -$33.09M(-0.9%) |
| Mar 2021 | - | -$10.14M(+29.8%) | -$33.39M(+4.5%) |
| Dec 2020 | -$31.95M(+37.7%) | -$7.82M(+10.4%) | -$31.95M(+3.0%) |
| Sep 2020 | - | -$7.08M(-15.2%) | -$31.01M(+3.3%) |
| Jun 2020 | - | -$8.35M(-4.0%) | -$30.03M(+10.7%) |
| Mar 2020 | - | -$8.70M(+26.4%) | -$27.12M(+16.9%) |
| Dec 2019 | -$23.20M(+68.9%) | -$6.88M(+12.7%) | -$23.20M(+16.7%) |
| Sep 2019 | - | -$6.11M(+12.2%) | -$19.87M(+14.1%) |
| Jun 2019 | - | -$5.44M(+14.0%) | -$17.42M(+12.7%) |
| Mar 2019 | - | -$4.77M(+34.2%) | -$15.46M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$13.73M(+6.9%) | -$3.56M(-2.5%) | -$13.73M(-14.5%) |
| Sep 2018 | - | -$3.65M(+4.9%) | -$16.06M(+6.8%) |
| Jun 2018 | - | -$3.48M(+14.2%) | -$15.04M(+3.5%) |
| Mar 2018 | - | -$3.05M(-48.2%) | -$14.53M(+13.0%) |
| Dec 2017 | -$12.85M(+54.4%) | -$5.88M(+123.5%) | -$12.85M(+46.0%) |
| Sep 2017 | - | -$2.63M(-11.4%) | -$8.81M(+8.1%) |
| Jun 2017 | - | -$2.97M(+116.2%) | -$8.14M(+9.0%) |
| Mar 2017 | - | -$1.37M(-25.1%) | -$7.47M(-27.9%) |
| Dec 2016 | -$8.32M(-31.5%) | -$1.83M(-6.9%) | -$10.36M(+35.9%) |
| Sep 2016 | - | -$1.97M(-14.2%) | -$7.62M(-14.8%) |
| Jun 2016 | - | -$2.29M(-46.2%) | -$8.95M(-7.7%) |
| Mar 2016 | - | -$4.26M(-571.9%) | -$9.70M(+23.4%) |
| Dec 2015 | -$12.16M(+33.5%) | $903.30K(-127.4%) | -$7.86M(-46.0%) |
| Sep 2015 | - | -$3.29M(+8.2%) | -$14.56M(+15.7%) |
| Jun 2015 | - | -$3.04M(+25.5%) | -$12.59M(+16.0%) |
| Mar 2015 | - | -$2.43M(-58.1%) | -$10.85M(+22.3%) |
| Dec 2014 | -$9.11M(+975.2%) | -$5.79M(+337.9%) | -$8.87M(+137.1%) |
| Sep 2014 | - | -$1.32M(+1.2%) | -$3.74M(+8.8%) |
| Jun 2014 | - | -$1.31M(+193.0%) | -$3.44M(+3.2%) |
| Mar 2014 | - | -$446.00K(-32.8%) | -$3.33M(+259.6%) |
| Dec 2013 | -$847.00K(-76.6%) | -$664.00K(-34.8%) | -$926.20K(+253.2%) |
| Sep 2013 | - | -$1.02M(-15.2%) | -$262.20K(-134.6%) |
| Jun 2013 | - | -$1.20M(-161.4%) | $756.80K(-61.4%) |
| Mar 2013 | - | $1.96M | $1.96M |
| Dec 2012 | -$3.62M | - | - |
FAQ
- What is Soleno Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Soleno Therapeutics?
- What is Soleno Therapeutics annual EBIT year-on-year change?
- What is Soleno Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly EBIT year-on-year change?
- What is Soleno Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Soleno Therapeutics?
- What is Soleno Therapeutics TTM EBIT year-on-year change?
What is Soleno Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SLNO is -$175.62M
What is the all time high annual EBIT for Soleno Therapeutics?
Soleno Therapeutics all-time high annual earnings before interest & taxes is -$847.00K
What is Soleno Therapeutics annual EBIT year-on-year change?
Over the past year, SLNO annual earnings before interest & taxes has changed by -$136.63M (-350.44%)
What is Soleno Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SLNO is -$42.41M
What is the all time high quarterly EBIT for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly earnings before interest & taxes is $1.96M
What is Soleno Therapeutics quarterly EBIT year-on-year change?
Over the past year, SLNO quarterly earnings before interest & taxes has changed by -$19.34M (-83.81%)
What is Soleno Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SLNO is -$194.96M
What is the all time high TTM EBIT for Soleno Therapeutics?
Soleno Therapeutics all-time high TTM earnings before interest & taxes is $1.96M
What is Soleno Therapeutics TTM EBIT year-on-year change?
Over the past year, SLNO TTM earnings before interest & taxes has changed by -$141.06M (-261.75%)